Reza Rezaei

5PUBLICATIONS
34CO-AUTHORS
Molecular targetsMedical biotechnology diagnostics (incl. biosensors)Cheminformatics and quantitative structure-activity relationshipsGene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 13, 2024
PD-L1 promotes oncolytic virus infection via a metabolic shift that inhibits the type I IFN pathway.

Jonathan J Hodgins, John Abou-Hamad, Colin Edward O'Dwyer

|Apr 03, 2021
A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 Seroconversion.

Taha Azad, Reza Rezaei, Ragunath Singaravelu

|Mar 06, 2021
Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.

Emily E F Brown, Reza Rezaei, Taylor R Jamieson

|Sep 03, 2020
Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization.

Taha Azad, Ragunath Singaravelu, Mathieu J F Crupi

|Jul 30, 2020
Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis.

Taha Azad, Reza Rezaei, Abera Surendran

Pageof 1

Frequent Collaborators

4 joint publications

Taha Azad

3 joint publications

Mathieu J F Crupi

2 joint publications

Emily E F Brown

2 joint publications

Zaid Taha